We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
Hollywood-style messages from politicians about beating the pandemic downplay the technical complexity
Sufferers who reported symptoms on tablet survived longer than those who did not
UK regulators are under pressure from Big Pharma as well as patients
Bristol-Myers skin cancer treatment also brings safety concerns over side effects
Treatments that turn the body into a weapon against tumours offer hope to thousands of patients
The man who was once dubbed the ‘Baron of Botox’
Critics question whether big pharma’s premium pricing model can endure
Critics say there is too much focus on new therapies even when benefits are modest
The EMBA graduate says we need to make our male colleagues more aware of what troubles women
International Edition
